Drug-resistant gonorrhoea is a growing threat: a South African case study

  06 November 2020

Gonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae. This infection affects 87 million  people every year across the world. It can lead to genital discharge, pregnancy complications and infertility. Gonorrhoea can be treated successfully with antibiotics.

Current first-line treatment is a ceftriaxone injection combined with azithromycin given as oral tablet. But in recent years, alarming reports emerged of these drugs failing to treat gonorrhoea patients. Drug-resistance has been reported in Asia, Europe and Australia.

 

Further reading: The Conversation
Author(s): The Conversation
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!